CytomX Therapeutics, Inc.
CTMX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001501989
No open-market purchases or sales by CytomX Therapeutics, Inc. insiders were filed in the last 90 days; 178 institutions reported holding it in 13F filings for Q2 2026, worth $799.0M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding CytomX Therapeutics, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 99 | 84 | −15 |
| Shares | 45.6M | 36.3M | −9.26M (−20.3%) |
| Value | $83.4M | $52.6M | −$30.8M (−36.9%) |
New holders (10)
Institutions that held CytomX Therapeutics, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Assenagon Asset Management S.A. | 1,065,392 | $1.54M | 0.01% |
| AlphaCentric Advisors LLC | 257,500 | $373.0K | 0.38% |
| Bridgeway Capital Management, LLC | 176,000 | $255.0K | 0.01% |
| Public Employees Retirement System of Ohio | 82,028 | $119.0K | 0.00% |
| Ameriprise Financial Inc | 74,853 | $109.0K | 0.00% |
| Charles Schwab Investment Management Inc | 42,221 | $62.0K | 0.00% |
| Magnus Financial Group LLC | 20,000 | $29.0K | 0.01% |
| Camden Capital, LLC | 15,000 | $22.0K | 0.01% |
| Beacon Capital Management, LLC | 5,000 | $9.00K | 0.00% |
| China Universal Asset Management Co., Ltd. | 617 | $1.00K | 0.00% |
Sold out (25)
Institutions that held CytomX Therapeutics, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.